vilanterol trifenilacetate
SpainDrugs containing this active substance
-
It is used to treat chronic obstructive pulmonary disease (COPD) in adults. It helps facilitate the entry and exit of air from the lungs by preventing the airway muscles from contracting.
Form: powder for inhalation, single-dose
Active substance Dosage umeclidinium bromide 74,2 µg vilanterol trifenilacetate 40 µg Manufacturer: Glaxosmithkline Trading Services Limited
-
It is used to treat chronic obstructive pulmonary disease (COPD) in adults. It helps facilitate the intake and release of air from the lungs by preventing the airway muscles from contracting.
Form: powder for inhalation, single-dose
Active substance Dosage umeclidinium bromide 65 µg vilanterol trifenilacetate 35,2 µg Manufacturer: Glaxosmithkline Trading Services Limited
-
It is used for the regular treatment of chronic obstructive pulmonary disease (COPD) in adults, and for the treatment of asthma in adults and adolescents aged 12 years or older.
Form: powder for inhalation, single-dose
Active substance Dosage vilanterol trifenilacetate 25 µg fluticasone furoate 200 µg Manufacturer: Glaxosmithkline Trading Services Limited
-
It is used for the regular treatment of chronic obstructive pulmonary disease (COPD) in adults, and for the treatment of asthma in adults and adolescents aged 12 years or older.
Form: powder for inhalation, single-dose
Active substance Dosage vilanterol trifenilacetate 25 µg fluticasone furoate 100 µg Manufacturer: Glaxosmithkline Trading Services Limited
-
It is used to treat chronic obstructive pulmonary disease (COPD) in adults, helping to reduce swelling and irritation in the airways to make breathing easier.
Form: powder for inhalation, single-dose
Active substance Dosage fluticasone furoate 92 µg umeclidinium bromide 55 µg vilanterol trifenilacetate 22 µg Manufacturer: Glaxosmithkline Trading Services Limited